COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study With Advanced Vaginal Tactile Imager

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01848626
Recruitment Status : Completed
First Posted : May 7, 2013
Last Update Posted : July 16, 2014
Information provided by (Responsible Party):
Artann Laboratories

Brief Summary:

The objectives of this study are:

  1. To collect data necessary for assessing the performance of advanced Vaginal Tactile Imager (VTI) and evaluating the probe ergonomic design, safety and patient tolerance;
  2. To assess the clinical suitability of the interface software to facilitate the data collection process and to get in vivo examination data for validation of visualization and analysis routines;
  3. To test the data collection technique and establish a reliable examination procedure.

Condition or disease
Investigative Techniques

Layout table for study information
Study Type : Observational
Actual Enrollment : 22 participants
Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Study With Advanced Vaginal Tactile Imager
Study Start Date : April 2013
Actual Primary Completion Date : January 2014
Actual Study Completion Date : March 2014

Primary Outcome Measures :
  1. Imaging performance [ Time Frame: 3 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Adult females, presenting to the urogynecological office for a vaginal examination with normal pelvic floor organs, referred to gynecologic examination due to pelvic organ prolapse concern or earlier diagnosed with pelvic organ prolapse, will be considered eligible as volunteers to be enrolled in the clinical studies.

Inclusion Criteria:

Adult women (over the age of 21) falling within one of the following groups:

  1. No evidence of pelvic floor disorder and no prior pelvic surgery;
  2. Stage 1 or 2 pelvic organ prolapse affecting one or more vaginal compartment.

Exclusion Criteria:

  1. Active skin infection or ulceration within the vagina
  2. Presence of a vaginal septum;
  3. Active cancer of the colon, rectum wall, cervix, vaginal, uterus or bladder;
  4. Ongoing radiation therapy for pelvic cancer;
  5. Impacted stool;
  6. Recent (less than three months) pelvic surgery;
  7. Significant pre-existing pelvic pain including levator ani syndrome, severe vaginismus or vulvodynia;
  8. Severe hemorrhoids;
  9. Surgically absent rectum or bladder;
  10. Significant circulatory or cardiac conditions that could cause excessive risk from the examination as determined by attending physician.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01848626

Layout table for location information
United States, New Jersey
Princeton Urogynecology
Princeton, New Jersey, United States, 08540
Sponsors and Collaborators
Artann Laboratories
Layout table for investigator information
Principal Investigator: Vladimir Egorov, PhD Artann Laboratories
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Artann Laboratories Identifier: NCT01848626    
Other Study ID Numbers: VTI 04
First Posted: May 7, 2013    Key Record Dates
Last Update Posted: July 16, 2014
Last Verified: July 2014